Under the project name KLS ONE, Karl and Christian Leibinger have set the goal of merging the five German companies of the KLS Martin Group – Karl Leibinger Medizintechnik GmbH & Co. KG (KLM), Mondeal Medical Systems GmbH, Rudolf Buck GmbH, Gebrüder Martin GmbH & Co .KG and KLS Martin GmbH & Co. KG – to become one company in the medium term. This is primarily a simplification of the corporate structure.
The Mühlheim-based company Karl Leibinger Medizintechnik initially plans to integrate Rudolf Buck GmbH and the medical technology company Mondeal Medical Systems GmbH, which is also based in Mühlheim, into the business operations of Karl Leibinger Medizintechnik.
The Karl Leibinger Group was founded by Ludwig Leibinger in Mühlheim in 1896 as a factory for surgical instruments and is now managed in the fourth and fifth generation by Karl and Christian Leibinger. The group of companies has been owned by the Leibinger family since it was founded, employs around 1,700 people worldwide and generated sales of around 300 million euros in 2020.
At the locations in Mühlheim, Freiburg, Jacksonville (USA) and Penang (Malaysia), implant systems for oral and maxillofacial surgery, neurosurgery, hand and foot surgery, surgical instruments, electrosurgical devices and surgical lasers, operating lights and sterilization containers are produced. In North and Central America, the products are sold through a subsidiary, in the rest of the world through Gebrüder Martin.
In 1923, Rudolf Buck was the initiator and co-founder of the marketing and sales company Gebrüder Martin. His own company, founded in 1928, rounds off the overall range of the KLS Martin Group in the field of surgical instruments and special products.
Mondeal Medical Systems GmbH has stood for service, quality, precision, tradition and a focus on results since 1994. The product range includes solutions for neurosurgery, oral and maxillofacial surgery, orthodontics, as well as hand and foot surgery. In 2019, the Karl Leibinger Group acquired the shares in Mondeal.
The integration of Rudolf Buck GmbH and Mondeal Medical Systems GmbH is expected to take place in spring 2022. Mondeal and Buck employees have already been informed. “We are now one step closer to our goal of becoming a company. It is important to us to develop synergies and solutions for meaningful integration in a joint exchange," says Karl Leibinger, Managing Director of the KLS Martin Group.
Christian Leibinger, Managing Partner of the KLS Martin Group, explains: "All employees of the companies mentioned will continue to work for the KLS Martin Group." Arno Fritz, Managing Director and founder of Mondeal: "I am firmly convinced that my life's work With the transition to the KLS Martin Group, Mondeal and all employees have a successful future ahead of them. Nowadays, a medical technology company can only withstand the growing regulatory requirements if it has the appropriate structures.”
In the course of the merger there will be staff transfers. It is planned that the majority of Mondeal and Buck employees will transfer to Karl Leibinger Medizintechnik. Individual areas will also switch to Gebrüder Martin. Mathias Fritz, Managing Director at Mondeal, and Joachim Klüppel, Managing Director at Buck, are also looking forward to being actively involved in the upcoming detailed planning of the integration.
Michael Martin, Managing Director of the KLS Martin Group, agrees: “We look forward to integrating the five locations into one company. By creating cross-site processes, interfaces can be reduced and processes simplified.”
“We are convinced that this is the right step for the future success of the KLS Martin Group. We are thus strengthening the competitiveness of the KLS Martin Group and making every single job even more secure in the long term,” summarizes Christian Leibinger.
The next step is the detailed planning of how the business operations of Buck and Mondeal can be integrated at Karl Leibinger Medizintechnik in the best possible way.
To the original article
